Chemours CC Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$29M+38.3% | -$47M-202% | $46M+112% | -$379M-7,480% | -$5M+54.5% | ||
| $79M-2.5% | $81M+1.3% | $80M-12.1% | $91M+3.4% | $88M+18.9% | ||
| $7M+75.0% | $4M-20.0% | $5M-28.6% | $7M+40.0% | $5M+66.7% | ||
| -$11M— | —— | —— | $111M+893% | -$14M— | ||
| $3M+50.0% | $2M-33.3% | $3M0.0% | $3M0.0% | $3M0.0% | ||
| $1M-80.0% | $5M-68.8% | $16M+60.0% | $10M+900% | $1M-50.0% | ||
| —— | —— | $7M— | —— | $1M— | ||
| -$58M+32.6% | -$86M— | —— | —— | -$105M-217% | ||
| -$17M— | $0+100% | -$6M+62.5% | -$16M+66.7% | -$48M-133% | ||
| -$8M-121% | $38M+1,167% | $3M-98.7% | $230M+2,456% | $9M0.0% | ||
| -$14M— | —— | $5M— | —— | $37M+223% | ||
| $0+100% | -$1M— | —— | —— | $0-100% | ||
| -$9M— | —— | —— | —— | $0+100% | ||
| $77M+129% | -$269M-2,345% | -$11M-117% | $63M-43.2% | $111M— | ||
| $6M— | —— | $7M-22.2% | $9M+28.6% | $7M— | ||
| -$44M-132% | $137M-6.2% | $146M+57.0% | $93M+183% | -$112M— | ||
| $49M+8.9% | $45M+9.8% | $41M-4.7% | $43M-48.8% | $84M-22.9% | ||
| $7M— | —— | $6M— | —— | —— | ||
| -$44M-2.3% | -$43M-22.9% | -$35M+16.7% | -$42M+51.2% | -$86M+19.6% | ||
| $13M-13.3% | $15M+15.4% | $13M0.0% | $13M-64.9% | $37M+2.8% | ||
| —— | —— | —— | —— | —— | ||
| $700M+7.2% | $653M— | —— | —— | —— | ||
| $2M— | —— | —— | —— | $0-100% | ||
| $3M+50.0% | $2M-60.0% | $5M+25.0% | $4M+33.3% | $3M0.0% | ||
| $2M— | —— | —— | —— | $1M— | ||
| $10M+233% | $3M— | —— | —— | —— | ||
| -$19M+48.6% | -$37M-640% | -$5M+81.5% | -$27M+52.6% | -$57M— | ||
| -$2M-200% | $2M-66.7% | $6M-60.0% | $15M+150% | $6M+132% | ||
| -$109M— | —— | —— | —— | -$249M— | ||
| —— | $62.75M0.0% | $62.75M0.0% | $62.75M0.0% | $62.75M-6.0% | ||
| —— | $18.5M0.0% | $18.5M0.0% | $18.5M0.0% | $18.5M-9.8% | ||
| $3M+50.0% | $2M-33.3% | $3M0.0% | $3M0.0% | $3M0.0% | ||
| $1M— | —— | —— | $4M0.0% | $4M+33.3% | ||
| —— | —— | $7M— | —— | $1M— | ||
| $6M— | —— | $7M-22.2% | $9M+28.6% | $7M— | ||
| $77M+129% | -$269M-2,345% | -$11M-117% | $63M-43.2% | $111M— | ||
| -$32M-207% | $30M-11.8% | $34M— | $0-100% | $51M+2.0% | ||
| $12M+113% | -$95M-532% | $22M-70.7% | $75M+1,600% | -$5M+86.1% | ||
| -$8M-121% | $38M+1,167% | $3M-98.7% | $230M+2,456% | $9M0.0% | ||
| $1M-80.0% | $5M-68.8% | $16M+60.0% | $10M+900% | $1M-50.0% | ||
| $3M— | —— | $1M— | —— | $2M+200% | ||
| $1M— | —— | —— | —— | —— | ||
| $7M— | —— | $6M— | —— | —— | ||
| $3M+50.0% | $2M-60.0% | $5M+25.0% | $4M+33.3% | $3M0.0% | ||
| $6M— | —— | —— | —— | —— | ||
| $10M+233% | $3M— | —— | —— | —— | ||
| $14M-22.2% | $18M+5.9% | $17M-5.6% | $18M-48.6% | $35M+59.1% | ||
| $700M+7.2% | $653M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $16M0.0% | $16M-5.9% | $17M-15.0% | $20M-25.9% | $27M+3.8% | ||
| $689M+3.1% | $668M+8,250% | $8M-92.2% | $103M+1,188% | $8M-98.3% | ||
| —— | $18.5M0.0% | $18.5M0.0% | $18.5M0.0% | $18.5M-9.8% | ||
| -$93M-201% | $92M— | —— | —— | -$196M— | ||
| -$93M-201% | $92M— | —— | —— | -$196M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Chemours's cash flow data come from?
- Every line is extracted from Chemours's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.